COLOSSEUMKLINIKKEN AS

0369 OSLO

Finances

Share Ownership

Return on Equity

130,99 %

Current Ratio

0,82

Debt-to-Equity Ratio

33,26

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 379 742 000	1 058 297 000	855 300 000	874 014 000
Net Income	38 599 000	27 146 000	1 300 000	34 811 000
Total Assets	1 379 237 000	691 150 000	547 908 000	583 230 000
Total Equity	29 467 000	70 063 000	62 027 000	36 647 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 379 742 000	1 058 297 000	855 300 000	874 014 000
Expenditure	1 294 253 000	983 281 000	827 387 000	820 713 000
Operating Profit	85 489 000	75 016 000	27 913 000	53 302 000
Financial Income	255 000	163 000	110 000	71 000
Financial Costs	31 830 000	17 589 000	22 896 000	2 766 000
Financial Balance	−31 575 000	−17 426 000	−22 786 000	−2 695 000
Earnings Before Tax	53 914 000	57 590 000	5 127 000	50 607 000
Tax	15 315 000	30 444 000	3 827 000	15 796 000
Net Income	38 599 000	27 146 000	1 300 000	34 811 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 076 788 000	540 752 000	460 141 000	478 410 000
Total Current Assets	302 449 000	150 398 000	87 767 000	104 820 000
Total Assets	1 379 237 000	691 150 000	547 908 000	583 230 000
Total Retained Equity	32 215 000	−6 383 000	−33 527 000	0
Total Equity	29 467 000	70 063 000	62 027 000	36 647 000
Total Long-Term Debt	979 983 000	394 328 000	297 816 000	299 461 000
Total Current Debt	369 786 000	226 759 000	188 065 000	247 122 000
Total Equity and Debt	1 379 236 000	691 150 000	547 908 000	583 230 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 379 653 000	1 058 102 000	845 159 000	873 459 000
Other Income	89 000	195 000	10 141 000	555 000
Revenue	1 379 742 000	1 058 297 000	855 300 000	874 014 000
Cost of Goods Sold	655 180 000	501 583 000	418 530 000	402 545 000
Salary Costs	289 412 000	221 265 000	193 219 000	205 608 000
Depreciation	139 747 000	99 003 000	86 114 000	77 458 000
Impairment	0	0	0	0
Expenditure	1 294 253 000	983 281 000	827 387 000	820 713 000
Operating Profit	85 489 000	75 016 000	27 913 000	53 302 000
Financial Income	255 000	163 000	110 000	71 000
Financial Costs	31 830 000	17 589 000	22 896 000	2 766 000
Financial Balance	−31 575 000	−17 426 000	−22 786 000	−2 695 000
Dividends	0	0	0	0
Net Income	38 599 000	27 146 000	1 300 000	34 811 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	858 506 000	388 117 000	340 444 000	374 708 000
Total Intangible Assets	858 506 000	388 117 000	347 854 000	374 708 000
Real Eastate	0	152 635 000	106 287 000	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	218 282 000	0	0	103 702 000
Total Tangible Assets	218 282 000	152 635 000	106 287 000	103 702 000
Total Fiancial Fixed Assets	0	0	6 000 000	0
Total Fixed Assets	1 076 788 000	540 752 000	460 141 000	478 410 000
Stock	38 852 000	21 256 000	17 465 000	16 234 000
Total Investments	0	0	0	0
Cash, Bank	29 220 000	10 022 000	16 552 000	35 748 000
Total Current Assets	302 449 000	150 398 000	87 767 000	104 820 000
Total Assets	1 379 237 000	691 150 000	547 908 000	583 230 000
Total Equity	29 467 000	70 063 000	62 027 000	36 647 000
Short-Term Group Debt	138 490 000	73 500 000	34 900 000	89 280 000
Total Long-Term Debt	979 983 000	394 328 000	297 816 000	299 461 000
Creditors	54 701 000	39 882 000	27 735 000	41 748 000
Unpaid Taxes	20 816 000	16 050 000	13 312 000	13 460 000
Dividends	0	0	0	0
Other Current Debt	152 163 000	97 205 000	112 118 000	100 529 000
Total Current Debt	369 786 000	226 759 000	188 065 000	247 122 000
Total Equity and Debt	1 379 236 000	691 150 000	547 908 000	583 230 000

Financial indicators	2022	2021	2020	2019
Return on Equity	130,99 %	38,75 %	2,1 %	94,99 %
Debt-to-Equity Ratio	33,26	5,63	4,8	8,17
Operating Profit Margin	6,2 %	7,09 %	3,26 %	6,1 %
Current Ratio	0,82	0,66	0,47	0,42
Quick Ratio	0,91	0,73	0,51	0,45
Equity Ratio	0,02	0,1	0,11	0,06
Gross Profit Margin	52,51 %	52,6 %	51,07 %	53,94 %